Autopsy report · NCT00236327
Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin Patch in Out-Patients With Chronic Cancer Pain
Cause of deathFunding or business
“Sponsor discontinued the study following the discovery of a number of incompletely sealed batches that were unusable.”
Life of this trial
- Registered 2 years 4 months after it had already started.
- Ran for about 11 months before it stopped.
- 34 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Janssen Cilag S.A.S.
- Sponsor type
- Industry
- Conditions
- Pain
- Interventions
- fentanyl
- Participants
- 34
Trials that died the same way
- KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
“Study discontinued due to sponsor decision.” - Use Muscadine Wine Nutraceuticals to Improve Brain Health, Cognition, and Mental Health
“Funding for this study was discontinued by the sponsor after the first year.” - Safety and Efficacy of Ustekinumab in Patients With Palmo-Plantar Pustular Psoriasis or With Palmo-Plantar Pustulosis
“Manufacturer ceased to produce vials used for this study.” - RNA Extraction and Amplification From Biopsy Specimens in Subjects With Metastatic Renal Cell Carcinoma (AGS-NTS-017)
“The sponsor's clinical program for the agent used in this study was discontinued.” - Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated
“Study discontinued due to futility.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.